Tag: dividend-stock
-
Abbott Laboratories (ABT) Medical Devices — Equity Research
Abbott Laboratories (ABT) earns a Buy rating on durable diagnostics and device moats, strong margins, and resilient cash generation. Exact Sciences adds growth optionality, but the pending deal also raises leverage and refinancing risk.
-
Verizon Communications Inc. (VZ) Wireless Network — Equity Research
Verizon Communications Inc. (VZ) is rated Hold as its scale and network moat remain intact, but leverage is elevated. With $200.9B of debt and a 0.60x current ratio, the investment case hinges on dividend support, fiber growth, and refinancing discipline.